1. Home
  2. GWAV vs OGEN Comparison

GWAV vs OGEN Comparison

Compare GWAV & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenwave Technology Solutions Inc.

GWAV

Greenwave Technology Solutions Inc.

HOLD

Current Price

$3.80

Market Cap

3.6M

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.80

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWAV
OGEN
Founded
2002
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.6M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
GWAV
OGEN
Price
$3.80
$0.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.4K
407.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.57
EPS
N/A
N/A
Revenue
$8,098,036.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
116184.26
N/A
52 Week Low
$0.07
$0.11
52 Week High
$24.00
$9.16

Technical Indicators

Market Signals
Indicator
GWAV
OGEN
Relative Strength Index (RSI) 38.83 53.01
Support Level $3.29 $0.78
Resistance Level $7.22 $0.90
Average True Range (ATR) 0.31 0.08
MACD 0.04 0.02
Stochastic Oscillator 34.51 48.09

Price Performance

Historical Comparison
GWAV
OGEN

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: